BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding a press release dated October 29, 2021, titled "Balaxi Pharmaceuticals reports 19% PAT growth YoY for Q2FY22, lays down strategy of backward integration to have a sustainable growth in frontiermarkets".
Press Release Oct 29 2021
Earlier from Balaxi Pharmaceuticals
- Press Release Oct 28 2021
- Press Release Jul 19 2021
- Press Release May 21 2021
- Press Release (Revised) Jan 20 2021